74. Oncotarget. 2017 Dec 30;9(7):7464-7475. doi: 10.18632/oncotarget.23779.eCollection 2018 Jan 26.Involvement of the FOXO6 transcriptional factor in breast carcinogenesis.Lallemand F(1), Petitalot A(1)(2), Vacher S(1), de Koning L(3), Taouis K(1),Lopez BS(4), Zinn-Justin S(5), Dalla-Venezia N(6), Chemlali W(1), SchnitzlerA(1), Lidereau R(1), Bieche I(1)(7), Caputo SM(2).Author information: (1)Service de génétique, unité de pharmacogénomique, Institut Curie, Paris,France.(2)Service de génétique, unité de génétique constitutionnelle, Institut Curie,Paris, France.(3)Département de transfert, Institut Curie, Paris, France.(4)CNRS UMR 8200, Gustave Roussy Cancer Institute, Université Paris-Saclay,équipe labélisée par la Ligue contre le cancer, Villejuif, France.(5)Laboratoire de biologie structurale et radiobiologie, IBITEC-S (CEA) and I2BC (UMR 9198, CEA, CNRS, Univ. Paris South), Gif-sur-Yvette, France.(6)Centre de Recherche en Cancérologie de Lyon (CRCL)/INSERM U1052-CNRS UMR5286, Lyon, France.(7)EA7331, Université Paris Descartes, Paris, France.In mammals, FOXO transcriptional factors form a family of four members (FOXO1, 3,4, and 6) involved in the modulation proliferation, apoptosis, andcarcinogenesis. The role of the FOXO family in breast cancer remains poorlyelucidated. According to the cellular context and the stage of the disease, FOXOscan have opposite effects on carcinogenesis. To study the role of FOXOs in breastcarcinogenesis in more detail, we examined their expression in normal tissues,breast cell lines, and a large series of breast tumours of human origin. We founda very low physiological level of FOXO6 expression in normal adult tissues andhigh levels of expression in foetal brain. FOXO gene expressions fluctuatespecifically in breast cancer cells compared to normal cells, suggesting thatthese genes may have different roles in breast carcinogenesis. For the firsttime, we have shown that, among the various FOXO genes, only FOXO6 was frequentlyhighly overexpressed in breast cell lines and tumours. We also found thatinhibition of the endogenous expression of FOXO6 by a specific siRNA inhibitedthe growth of the human breast cell lines MDA-MB-468 and HCC-38. FACS and Westernblot analysis showed that inhibition of endogenous expression of FOXO6 inducedaccumulation of cells in G0/G1 phase of the cell cycle, but not apoptosis. These results tend to demonstrate that the overexpression of the human FOXO6 gene that we highlighted in the breast tumors stimulates breast carcinogenesis byactivating breast cancer cell proliferation.DOI: 10.18632/oncotarget.23779 PMCID: PMC5800916PMID: 29484124 